Precigen

Precigen, Inc.
Traded as	Nasdaq: PGEN; Russell 2000 Component
Industry	Biotechnology
Founded	May 21, 1998
Headquarters	Germantown, Maryland, US
Revenue	$91 million (2019)
Number of employees	600
Website	precigen.com

Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.

Intrexon was founded in 1998, and is headquartered in Germantown, Maryland.^[2]^[3] With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.^[4]

^ "Precigen Revenue 2012-2021 | PGEN".
^ "Intrexon Corporation: Private Company Information". Bloomberg. Retrieved 2017-06-26.
^ "Intrexon Corp (XON) Company Profile". Reuters.com. Retrieved 2017-06-26.^{[dead link]}
^ "FAQ | Intrexon". Intrexon InvestorRoom. Retrieved 2018-03-28.

[1] "Precigen Revenue 2012-2021 | PGEN".

[2] "Intrexon Corporation: Private Company Information". Bloomberg. Retrieved 2017-06-26.

[3] "Intrexon Corp (XON) Company Profile". Reuters.com. Retrieved 2017-06-26.^{[dead link]}

[4] "FAQ | Intrexon". Intrexon InvestorRoom. Retrieved 2018-03-28.

[1]

[2]

[3]

[4]


Traded as	Nasdaq: PGEN Russell 2000 Component
Industry	Biotechnology
Founded	May 21, 1998; 26 years ago (1998-05-21)
Headquarters	Germantown, Maryland , US
Revenue	$91 million (2019)^[1]
Number of employees	600
Website	precigen.com